| scholarly article | Q13442814 |
| P50 | author | Tom Huizinga | Q77086497 |
| P2093 | author name string | Cornelia F Allaart | |
| Ben A C Dijkmans | |||
| Yvonne P M Goekoop-Ruiterman | |||
| Pit J S M Kerstens | |||
| Irene Speyer | |||
| Harry M J Hulsmans | |||
| Jeska K de Vries-Bouwstra | |||
| Michiel V van Krugten | |||
| Naomi B Klarenbeek | |||
| Sjoerd M van der Kooij | |||
| Tineke J W Huizinga | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1342-1345 | |
| P577 | publication date | 2010-05-14 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial | |
| P478 | volume | 69 |
| Q43826908 | A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. |
| Q89546849 | Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats |
| Q83986921 | Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis |
| Q59303860 | Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c |
| Q38204350 | Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis |
| Q97566245 | Biological therapy safety in chronic inflammatory arthropathy patients |
| Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
| Q36218375 | Cardiovascular disease and rheumatoid arthritis: an update |
| Q30358256 | Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure |
| Q51329120 | Effect of tumor necrosis factor-α inhibitors on ambulatory 24-h blood pressure. |
| Q43482103 | Effects of infliximab treatment in terms of cardiovascular risk and insulin resistance in ankylosing spondylitis patients |
| Q54060732 | Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. |
| Q92355252 | Impaired renal functions in Pakistani cohort of rheumatoid arthritis |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q46598130 | Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients |
| Q52583114 | Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure. |
| Q88347952 | Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population |
| Q37894193 | TNF alpha antagonist therapy and safety monitoring |
| Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
| Q38168952 | The intelligent use of systemic glucocorticoids in rheumatoid arthritis |
| Q33743130 | The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality |
| Q33871929 | Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. |
| Q84815164 | [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis] |
Search more.